UBS Group’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
UBS Group's QGEN Position: Q2 2026 in Review
UBS Group increased its Qiagen (QGEN) stake by 139% in Q2 2026, buying an estimated $73.9M and bringing the position to 3,419,195 shares worth $134M. The position accounts for 0.02% of the portfolio, ranked #923.
UBS Group first reported a position in QGEN in Q1 2017 and has held it in 38 quarters since. The position peaked at $215M in Q1 2020. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- UBS Group held 3,419,195 shares of Qiagen worth $134M as of Q2 2026.
- UBS Group bought 1,990,888 Qiagen shares in Q2 2026, an estimated $73.9M.
- Qiagen made up 0.02% of UBS Group's portfolio in Q2 2026, its #923 holding.
- UBS Group first reported a position in Qiagen in Q1 2017 and has held it in 38 quarters since.
- UBS Group's Qiagen position peaked at $215M in Q1 2020.
- 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.